Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT01837251
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2013-04-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Sponsor:
AGO Research GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-16
First Submit QC Date:
None
Study First Post Date:
2013-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-08
Last Update Post Date:
2021-07-13
Last Update Post Date Type:
ACTUAL